Day: November 20, 2024

LPL Financial Welcomes Strata Financial Group

Written by Customer Service on November 20, 2024. Posted in Public Companies.

SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC, announced today that financial advisors Anthony “Tony” Campagni, CFP®, Ronald Jurczynski, CPA/PFS™, Mitchell Romeo, CPWA®, CPFA®, Kyle Hancharick, CFP®, and Dominic Elmo of Ohio-based Strata Financial Group have joined LPL Financial’s broker-dealer, RIA and custodial platforms. The advisors reported serving more than $350 million in advisory, brokerage and retirement plan assets,* and they join LPL from Osaic. Strata Financial Group was founded in 1998 by Campagni and the late Rino Romeo — Mitchell Romeo’s uncle — and currently operates in two Ohio locations: Sheffield Village, where the team serves the greater Cleveland area, and Dublin, serving the Columbus area. The advisors take a team-based approach to offering personalized strategic financial plans, tax...

Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

Written by Customer Service on November 20, 2024. Posted in Public Companies.

The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025 Phase III Clinical Trial is Evaluating the TAMP™ (Trans-Arterial Micro-Perfusion) Therapy Platform for the Treatment of Locally Advanced Pancreatic Cancer LOS ALTOS, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and offering RenovoCath®, a novel, FDA-cleared local drug-delivery platform, announced today that the Northwell Health Cancer Institute (“NHCI”) in New Hyde Park, NY is enrolling patients with locally advanced pancreatic cancer (LAPC) in the Company’s ongoing pivotal Phase III TIGeR-PaC clinical trial. NHCI joins esteemed...

StoryCatch Partners Acquires EmpiraMed

Written by Customer Service on November 20, 2024. Posted in Mergers And Acquisitions.

Combined organization will unlock patterns in complex participant populations, driving physical and mental health improvement WELLESLEY HILLS, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) — StoryCatch Partners, a Public Benefit Corporation leveraging the power of individual stories to improve mental and physical wellbeing, today announced that it has acquired Maynard, Mass.-based EmpiraMed Inc., a digital health technology leader in the field of virtual clinical studies for real-world evidence. EmpiraMed performs post-market, prospective, virtual clinical studies to generate real-world evidence for life sciences, pioneering site-less virtual studies. Its software helps clients produce evidence for expanding market access, deploy patient-centered rare disease registries, and support faster regulatory approval of new indications and label...

YY Group Holding Celebrates Hong Ye Group’s Wins for Excellence in Workplace and Cleaning Innovation

Written by Customer Service on November 20, 2024. Posted in Public Companies.

SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”) is proud to congratulate its subsidiary, Hong Ye Group, on receiving two prestigious awards: the HR Asia Best Companies to Work for in Asia 2024 and the Best Cleaning Company at the Let’s Observe Ourselves Awards (LOO Awards). HR Asia Best Companies to Work for in Asia 2024 On November 15, Hong Ye Group was celebrated among Asia’s top employers at the HR Asia Best Companies to Work for in Asia 2024 awards ceremony at Marina Bay Sands, Singapore. Rachel Xu, Chief Human Resources Officer (CHRO) of YY Group Holding Limited, proudly accepted the award on behalf of the company. Mike Fu, CEO of YY Group Holding Limited, expressed his gratitude for the recognition:“We are thrilled to be named one of Asia’s...

Reborn Coffee Provides Third Quarter 2024 Corporate Update and Financial Results

Written by Customer Service on November 20, 2024. Posted in Earnings Releases And Operating Results.

BREA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) — Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee industry, has reported its financial and operational results for the third quarter ended September 30, 2024. Key Financial and Operational HighlightsDespite higher food costs, in the nine months ending September 30, 2024, revenue was steady at $4.1 million as compared to the same period revenue in 2023. Company-operated store gross margins for nine months ended September 30, 2024, increased to 72% compared to 68% for the same period in 2023. Ended Q3’24 with 12 open locations, with 1 location in development. Q3’24 wholesale and online sales grew 432% to $140,407 from $26,401 in Q3’23.Q3 2024 and Subsequent EventsAcquired a 58% stake in Bbang Ssaem Bakery, one of Korea’s most iconic bakery brands...

Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

Written by Customer Service on November 20, 2024. Posted in Public Companies.

GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that the Company’s management will be attending and presenting at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference taking place December 3-4, 2024, in Boca Raton, Florida. Ilan Hadar, Chief Executive Officer will deliver a company presentation titled “Transforming Cancer Care: Silexion Therapeutics’ Innovative Approach to Pancreatic Cancer” on December 4, 2024 at 11:30 am. A replay of the presentation will be posted, when available, to Silexion’s website on the Presentation & Events page of the investors section. The Company’s management team will be available for one-on-one meetings throughout the...

Nano Dimension Announces Q3/2024 Results – The Best 3rd Quarter in the Company’s History

Written by Customer Service on November 20, 2024. Posted in Earnings Releases And Operating Results.

Revenue $14.9M, Up 22% from the Same Period in 2023 Announced Two Transformational M&A Agreements in Q3/24 Alone – With Desktop Metal and Markforged Gross Margin Higher48.2% in Q3/2024, Up 4.0% From Q3/2023 46.6% in the First Nine Months of 2024, Up 2.6% From the Same Period in 2023 Adjusted Gross Margin Higher50.5% in Q3/2024, Up 2.5% From Q3/2023 Net Cash Burn Reduced Substantially$3M in Q3/2024, Down From $16M in Q3/2023 – a Decrease of 80% The Company Continues to Urge Shareholders to Vote by December 1st, 2024 for Upcoming Annual General Meeting to Protect This Continued Success Conference Call to be Held Today at 9:00 a.m. ET WALTHAM, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional...

Stock Yards Bancorp Declares Quarterly Cash Dividend of $0.31 Per Common Share

Written by Customer Service on November 20, 2024. Posted in Dividend Reports And Estimates.

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per common share. The dividend will be paid on December 31, 2024, to stockholders of record as of December 16, 2024. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $8.44 billion in assets, was incorporated in 1988 as a bank holding company. It is the parent company of Stock Yards Bank & Trust Company, which was established in 1904. The Company’s common shares trade on The NASDAQ Stock Market under the symbol “SYBT.” For more information...

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Written by Customer Service on November 20, 2024. Posted in Public Companies.

Reductions also seen in comorbid anxiety and depression symptoms BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the publication of positive feasibility clinical data evaluating the analgesic effects of deep transcranial magnetic stimulation (Deep TMS™) in patients with peripheral neuropathic pain. The results were published in the Neuromodulation journal, in a peer-reviewed article entitled, “H-Coil Repetitive Transcranial Magnetic Stimulation Relieves Pain and Symptoms of Anxiety and Depression in Patients with Chronic Peripheral Neuropathic Pain: A Randomized Sham-Controlled Crossover Study.” The double-blind,...

Apica Acquires Orson to Transform Enterprise Test Data Management

Written by Customer Service on November 20, 2024. Posted in Mergers And Acquisitions.

STOCKHOLM and EL SEGUNDO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) — Apica, the intelligent data management platform, today announced the acquisition of Orson, an innovative test data orchestration platform. This strategic acquisition strengthens Apica’s position in the DevOps marketplace by combining industry-leading synthetic monitoring capabilities with advanced test data orchestration, enabling organizations to build more robust monitoring scenarios through accelerated data variety generation. The acquisition combines Apica’s data management expertise in synthetic monitoring and observability with Orson’s advanced test data orchestration capabilities. This integration enables teams to self-service generate comprehensive test data sets derived from production patterns while maintaining compliance with data privacy...

Day: November 20, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals